Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII

被引:22
|
作者
Guzel, Ozlen [1 ,2 ]
Maresca, Alfonso [1 ]
Scozzafava, Andrea [1 ]
Salman, Aydin [2 ]
Balaban, Alexandru T. [3 ]
Supuran, Claudiu T. [1 ]
机构
[1] Univ Florence, Lab Chim Bioinorgan, Rm 188,Via Lastruccia 3, I-50019 Florence, Italy
[2] Istanbul Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34116 Istanbul, Turkey
[3] Texas A&M Univ, Galveston, TX 77551 USA
关键词
Carbonic anhydrase; Tumor-associated isoform; CA IX; CA XII; Sulfonamide; Pyridinium salt; Antitumor agent; IN-VIVO SELECTIVITY; X-RAY; ISOZYME-II; THERAPEUTIC APPLICATIONS; ANTITUMOR SULFONAMIDE; MAMMALIAN ISOFORMS; CA-IX; DESIGN; TARGET; IV;
D O I
10.1016/j.bmcl.2009.04.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides possessing various 2-, 3- or 4- substituted phenyl groups with methyl-, halogeno- and methoxy-functionalities, or a perfluorophenyl moiety, has been derivatized by reaction with 2,4,6-trimethylpyrylium perchlorate. The new sulfonamides were evaluated as inhibitors of four mammalian carbonic anhydrase (CA, EC 4.2.1.1) isoforms, that is, CA I, II (cytosolic), CA IX and XII (transmembrane, tumor-associated forms). Excellent inhibitory activity was observed against hCA IX with most of these sulfonamides, and against hCA XII with some of the new compounds. These compounds were generally less effective inhibitors of hCA II. Being membrane impermeant, these positively-charged sulfonamides are interesting candidates for targeting the tumor-associated CA IX and XII, as possible diagnostic tools or therapeutic agents. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2931 / 2934
页数:4
相关论文
共 34 条
  • [31] Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors
    Mishra, Chandra Bhushan
    Kumari, Shikha
    Angeli, Andrea
    Monti, Simona Maria
    Buonanno, Martina
    Prakash, Amresh
    Tiwari, Manisha
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 : 174 - 179
  • [32] Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides
    Yamali, Cem
    Sakagami, Hiroshi
    Uesawa, Yoshihiro
    Kurosaki, Kota
    Satoh, Keitaro
    Masuda, Yoshiko
    Yokose, Satoshi
    Ece, Abdulilah
    Bua, Silvia
    Angeli, Andrea
    Supuran, Claudiu T.
    Gul, Halise Inci
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
  • [33] Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors
    Wu, Yumeng
    Tang, Chengrun
    Rui, Ruomei
    Yang, Liumeng
    Ding, Wei
    Wang, Jiangyuan
    Li, Yiming
    Lai, Christopher C.
    Wang, Yueping
    Luo, Ronghua
    Xiao, Weilie
    Zhang, Hongbing
    Zheng, Yongtang
    He, Yanping
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (03) : 512 - 528
  • [34] Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives
    Kocyigit, Umit M.
    Budak, Yakup
    Gurdere, Meliha Burcu
    Tekin, Saban
    Koprulu, Tugba Kul
    Erturk, Fatih
    Ozcan, Kezban
    Gulcin, Ilhami
    Ceylan, Mustafa
    BIOORGANIC CHEMISTRY, 2017, 70 : 118 - 125